These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25769)

  • 1. Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis.
    Conzelmann E; Sandhoff K; Nehrkorn H; Geiger B; Arnon R
    Eur J Biochem; 1978 Mar; 84(1):27-33. PubMed ID: 25769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of hexosaminidase A isolated from the liver of a patient with a rare form (AB variant) of infantile GM2 gangliosidosis and control tissues.
    Sandhoff K; Conzelmann E; Nehrkorn H
    Adv Exp Med Biol; 1978; 101():727-30. PubMed ID: 96668
    [No Abstract]   [Full Text] [Related]  

  • 4. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.
    Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K
    EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
    Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
    Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
    Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
    Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
    Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates.
    Bach G; Suzuki K
    J Biol Chem; 1975 Feb; 250(4):1328-32. PubMed ID: 1112809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.
    Kytzia HJ; Hinrichs U; Sandhoff K
    Hum Genet; 1984; 67(4):414-8. PubMed ID: 6436167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
    Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
    Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
    Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemistry and genetics of gangliosidoses.
    Sandhoff K; Christomanou H
    Hum Genet; 1979; 50(2):107-43. PubMed ID: 116955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
    Kytzia HJ; Sandhoff K
    J Biol Chem; 1985 Jun; 260(12):7568-72. PubMed ID: 3158659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis.
    Hirabayashi Y; Li YT; Li SC
    J Neurochem; 1983 Jan; 40(1):168-75. PubMed ID: 6848657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical and biochemical investigation of hexosaminidase S.
    Geiger B; Arnon R; Sandhoff K
    Am J Hum Genet; 1977 Sep; 29(5):508-22. PubMed ID: 409285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.